middle.news
Biome Launches Groundbreaking Clinical Trial for Gut Health Probiotic
8:36am on Monday 15th of December, 2025 AEDT
•
Healthcare
Read Story
Biome Launches Groundbreaking Clinical Trial for Gut Health Probiotic
8:36am on Monday 15th of December, 2025 AEDT
Key Points
First human trial for proprietary probiotic BMB18 registered and ethics approval submitted
Randomised, double-blind, placebo-controlled study with 240 participants planned for February 2026
Trial targets digestive symptoms and mood or sleep disturbances
In vitro studies showed BMB18 modulates immune response and supports gut integrity
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Biome Australia (ASX:BIO)
OPEN ARTICLE